Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.
SkinHealth Systems is back in focus after the updated fair value estimate fell about 21% from US$1.69 to US$1.34, while some analysts are still pointing to a lower but intact price target of US$2.00. Bulls and bears are working from the same reset, using the revised target to argue either for patience as the story plays out or for caution around execution and competitive pressure. In the sections that follow, you will see what is driving these views and how to follow the evolving narrative around this stock.
Analyst Price Targets don’t always capture the full story. Head over to our Company Report to find new ways to value SkinHealth Systems.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
Roth Capital keeps a Buy rating on SkinHealth…
